Application of carbonyl reductase mutants in the synthesis of chiral ortho-halogenated-α-phenylethanol
A mutant and reductase technology, which is applied in the field of biocatalysis and protein engineering, can solve the problems that the catalytic activity cannot meet the requirements of industrial production, and achieve the effects of good industrial application development prospects, high stereoselectivity, and easy preparation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0032] The method for preparing a mutant of the above-mentioned carbonyl reductase BaSDR1 is characterized in that the method comprises the following steps: cultivating a recombinant expression transformant of the carbonyl reductase mutant, and inducing the recombinant carbonyl reductase mutant protein; wherein, culturing the recombinant expression The medium used for the transformant is LB medium, including the following: peptone 10g / L, yeast extract 5g / L, sodium chloride 10g / L, pH 7.2; recombinant Escherichia coli is inoculated into the LB medium containing kanamycin Medium culture, when the optical density OD600 of the culture solution reaches 0.5-0.7, under the induction of the final concentration of 0.1-1.0mM isopropyl-β-D-thiogalactopyranoside (IPTG), it can be obtained. The above reaction conditions can be selected according to conventional conditions used in the art, as long as the transformant can grow and produce the carbonyl reductase mutant protein.
[0033] In the...
Embodiment 1
[0034] Embodiment 1: the construction of above-mentioned mutant:
[0035] Using the oligonucleotide fragment containing the mutation point as a primer, as shown in Table 1, the QuickChangeTM method was used to amplify the pET-30a recombinant plasmid containing the carbonyl reductase BaSDR1 gene.
[0036] Table 1 Mutant construction primers
[0037]
[0038] a Mutation sites are underlined.
[0039] PCR reaction system: upstream primer 10 μM, 1.0 μL; downstream primer 10 μM, 1.0 μL; recombinant plasmid template, 10 ng; PrimerSTAR Max DNA Polymerase (2X), 12.5 μL; add ddH 2 O to a total volume of 25 µL.
[0040] PCR program: step (1) 98°C, 1min; step (2) 98°C, 10s; step (3) 55°C, 10s; step (4) 72°C, 6min. Steps (2)-(4) were cycled 15 times and then cooled to 4°C. Get the PCR product.
[0041] After the PCR product was washed, it was digested with the restriction endonuclease DpnI that specifically recognizes the methylation site to degrade the template plasmid. Enzyme ...
Embodiment 2
[0043] Example 2: Induced expression of the above-mentioned carbonyl reductase mutants:
[0044] The engineered bacteria constructed in Example 1 were inoculated into LB liquid medium containing 50 μg / mL kanamycin, cultivated overnight at 37° C., and then inoculated with 1% inoculum size (v / v) into LB liquid medium containing 50 μg / mL kanamycin. In 50mL LB medium, cultured at 37°C and 200rpm until the cell concentration OD600 to about 0.6, added IPTG with a final concentration of 0.1 mM, induced culture at 30°C for 6 hours, and centrifuged at 4°C and 4000rpm for 10min to collect the bacterial cells. Store at -80°C for later use.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com